/ /

Gretchen L Schwenker, PhD
Why not induce everyone at 39 weeks?
This debate posed the question: "If no elective inductions before 39 weeks, why not induce everyone at 39 weeks?" The debate looked at the feasibility of induction as well as the safety for mother and baby.
Novel prenatal care model improves patient outcomes
The need to keep patients satisfied and provide optimal prenatal care can be stressful. This presentation looked at a new care model that may reduce the stress while providing safe prenatal care to your patients.
Meeting the needs for transition-related care of transgender patients
Transgender patients who visit your practice will have needs specific to their desire to transition. This presentation examined how ob/gyns can bring their medical expertise and support to help these patients obtain the best possible outcomes.
HPV co-testing guidelines: Are you adhering?
Co-testing for human papillomavirus is the recommended screening type, but some physicians may not be testing according to recent guidelines. This session compared ob/gyns to family medicine physicians to see how they stacked up and how well ob/gyns were meeting the guidelines.
What patients think about flu and Tdap vaccination in pregnancy
Fear of vaccines and potential adverse events isn’t just a problem in the world of pediatrics. This session looked at what can be done to increase acceptance of vaccines that can greatly improve outcomes for mother and baby.
Safely delivering monoamniotic monochorionic twins
Monoamniotic monochorionic twins pose a particular challenge, with a recent ACOG bulletin stating that cesarean was the safest course of delivery. This session asked whether cesarean delivery was the only option for safe delivery.
Postpartum readmission: Are yours increasing?
Are postpartum readmissions becoming more common than they were in the past? This session examined the current trends and looked at complex reasons behind the trend.
Home birth after prior cesarean: What are the risks?
Home birth can carry risks, regardless of whether the woman has previously delivered, and prior cesarean delivery can also carry risks. This session examined the risks that can occur among women who choose home birth with a history of at least one cesarean delivery.
Highlights of ACOG’s 64th annual meeting
The 2016 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists runs Saturday, May 14th, to Tuesday, May 17th, at the Washington Convention Center in Washington, D.C.
Breast cancer drug research roundup from ASCO
Among the many poster sessions being presented at the 2015 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL, are several on the latest trials that are planned to evaluate potential treatment options for breast cancer. These trials include 1 phase 2 study and 3 phase 3 studies.